Literature DB >> 31159629

Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia.

Eleni Poptsi1,2, Despina Moraitou1,2, Marina Eleftheriou1, Fotini Kounti-Zafeiropoulou3, Chrysa Papasozomenou1, Christina Agogiatou1, Evaggelia Bakoglidou1, Georgia Batsila1, Despina Liapi1, Nefeli Markou1, Evdokia Nikolaidou1, Fani Ouzouni1, Aikaterini Soumpourou1, Maria Vasiloglou1, Magda Tsolaki1,4.   

Abstract

OBJECTIVE: The aim of the study was to provide normative data for the MoCA in a Greek cohort of people older than 60 years who meet criteria for subjective cognitive decline (SCD), mild cognitive impairment (MCI), or dementia in order to optimize cutoff scores for each diagnostic group.
METHOD: Seven hundred forty-six community-dwelling older adults, visitors of the Day Center of Alzheimer Hellas were randomly chosen. Three hundred seventy-nine of them met the criteria for dementia, 245 for MCI and 122 for SCD.
RESULTS: Initial statistical analyses showed that the total MoCA score is not affected by gender (P = .164), or age (P = .144) but is affected by educational level (P < .001). A cutoff score of 23 for low educational level (≤6 years) can distinguish people with SCD from MCI (sensitivity 71.4%, specificity 84.2%), while 26 is the cutoff score for middle educational level (7-12 years; sensitivity 73.2%, specificity 67.0%) and high educational level (≥13 years; sensitivity 77.6%, specificity 74.7%). Montreal Cognitive Assessment can discriminate older adults with SCD from dementia, with a cutoff score of 20 for low educational level (sensitivity 100%, specificity 92.3%) and a cutoff score 23 for middle educational level (sensitivity 97.6%, specificity 92.7%) and high educational level (sensitivity 98.5%, specificity 100%).
CONCLUSION: Montreal Cognitive Assessment is not affected by age or gender but is affected by the educational level. The discriminant potential of MoCA between SCD and MCI is good, while the discrimination of SCD from dementia is excellent.

Entities:  

Keywords:  assessment; neurocognitive disorders; neuropsychology; normatives; psychometric tests; screening tools

Mesh:

Year:  2019        PMID: 31159629     DOI: 10.1177/0891988719853046

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  5 in total

1.  Attentional prioritization in dual-task walking: Effects of stroke, environment, and instructed focus.

Authors:  Prudence Plummer; Lori Altmann; Jody Feld; Lisa Zukowski; Bijan Najafi; Carol Giuliani
Journal:  Gait Posture       Date:  2020-04-09       Impact factor: 2.840

2.  Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults.

Authors:  Lambros Messinis; Grigorios Nasios; Antonios Mougias; Panayiotis Patrikelis; Sonia Malefaki; Vasileios Panagiotopoulos; Aikaterini Ntoskou Messini; Christos Bakirtzis; Nikolaos Grigoriadis; Panagiotis Ioannidis; Stella Bairami; Valentina Papadopoulou; Phillipos Gourzis
Journal:  Healthcare (Basel)       Date:  2022-05-13

3.  Influence of Social and Demographic Factors on the Montreal Cognitive Assessment (MoCA) Test in Rural Population of North-Eastern Greece.

Authors:  Anna Tsiakiri; Konstantinos Vadikolias; Grigorios Tripsianis; Pinelopi Vlotinou; Aspasia Serdari; Aikaterini Terzoudi; Ioannis Heliopoulos
Journal:  Geriatrics (Basel)       Date:  2021-04-17

4.  A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls.

Authors:  Paraskevi Iliadou; Ioannis Paliokas; Stelios Zygouris; Eftychia Lazarou; Konstantinos Votis; Dimitrios Tzovaras; Magdalini Tsolaki
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Similar Theory of Mind Deficits in Community Dwelling Older Adults with Vascular Risk Profile and Patients with Mild Cognitive Impairment: The Case of Paradoxical Sarcasm Comprehension.

Authors:  Glykeria Tsentidou; Despina Moraitou; Magda Tsolaki
Journal:  Brain Sci       Date:  2021-05-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.